Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Trump Praises FDA, But May Leave Firms Queasy With Pricing, Right-To-Try Comments

Jan 31 2018

• By Michael Cipriano

Trump_Donald_160716_1200x675

Related Content

Right-To-Try Legislation Must Change Language To Narrow Spectrum Of Patients, Gottlieb Says

Oct 04 2017

Drug Pricing: US Senate Hearings Conclude With No Clear View On Legislation

Dec 12 2017

Expanded Access Data Supported Lutathera Approval, US FDA Notes

Jan 29 2018

Trump Emphasizes Foreign Drug Prices At Alex Azar's Swearing In

Jan 30 2018

US FDA Commissioner A 'Star' At Davos: Hopefully Not A Bad Omen

Jan 30 2018

Trump Slams FDA Regulations In Joint Session Of Congress

Mar 01 2017

Related Companies

Eli Lilly and Company

Additional Topics

United States Drug Review Pricing Debate Regulation BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window